[1] Orvigand C, Abrams M J.Medicinal inorganic chemistry: Introduction[J].Chem Rev,1999, 99(9): 2201-2204.
[2] O'Connor M,Kellett A,McCann M,et al.Copper(Ⅱ) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitrocytotoxicity against cisplatin sensitive and resistant cancer cell lines[J].J Med Chem,2012,55(5):1957-1968.
[3] Tarushi A,Totta X,Papadopoulos A,et al.Antioxidant activity and interaction with DNA and albumins of zinc-tolfenamato complexes.Crystal structure of [Zn(tolfenamato)2(2,2'-dipyridyl ketoneoxime)2][J].Eur J Med Chem,2014,(74):187-198.
[4] Stephanie S,Annie C,Michel T,et al.A novel copper(II) mononuclear complex with the non- steroidal anti-inflammatory drug diclofenac:Structural characterization and biological activity[J].Inorg Biochem,2013,(120):39-43.
[5] Tamasi G,Bernini C,Corbini G,et al.Synthesis,spectroscopic and DFT structural characteriz- ation of two novel ruthenium(Ⅲ) oxicam complexes.In vivo evaluation of anti-inflammatory and gastric damaging activities[J].Inorg Biochem,2014,(134):25-35.
[6] Daniela Di Leo,Francesco Berrettini,Renzo Cini.Synthesis of platinum(Ⅱ)-piroxicam compounds. Crystal structure of trans-dichloro (ƞ2-ethene)(piroxicam)platinum(Ⅱ)[J].Journal of the Chemical Society Dalton Transactions,1998,(12):1993-2000.
[7] Cini R.Synthesis,crystal structural and molecular orbital investigation of the first platinum complex of piroxicam[J].Journal of the Chemical Society Dalton Transactions,1996,(1):111-116.
[8] Cini R,Giorgi G,Cinquantini A,et al.Metal complexes of the anti-inflammatory drug piroxicam[J].Inorg.Chem,1990,29(26):5179-5200.
[9] Sordelli DO,Fontán PA,Amura CR,et al.Piroxicam-copper complexes:Inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro[J].Agents Actions,1993,38(3-4):196-201.
[10] Tamasi G,Serinelli F,Consumi M,et al.Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs.X-ray structures of new copper(II)-piroxicam and-isoxicam complex molecules[J],Journal of Inorganic Biochemistry,2008,102(10): 1862-1873.
[11] Hadjikakou SK,Demertzis MA,Miller JR,et al.Synthesis and characterisation of the first organotin complex of piroxicam. An extended network system via non-hydrogen, hydrogen bonding linkages and C-H…π contacts[J].Journal of the Chemical Society Dalton Transactions, 1999,5(5):663-666.
[12] JAncso N,Jancso-Gabor A.The effect of anticoagulants on inflammatory tissue reactions[J]. Naunyn Schmiedebergs Arch Exp Pathol,Pharmakol,1960,238:83-84.
[13] 曾正志,吴集贵,邓汝温.稀土化合物的药理学性质[J].化学通报,1986,(11):28-31.
[14] 吴集贵,邓汝温,曾正志,等.稀土在医药中的应用研究概况[J].有色金属与稀土应用,1994,(1):19-28.
[15] 杨晓改,杨晓达,王夔.钒化合物生物效应的化学基础和药用前景-金属药物研究的化学问题[J].化学进展,2002,14(4):279-286.
[16] Thompson KH,Orvig C.Editorial: lanthanide compounds for therapeutic and diagnostic applications[J].Chem Soc Rev,2006,35(6):499. |
